0001213900-23-001717.txt : 20230109 0001213900-23-001717.hdr.sgml : 20230109 20230109170047 ACCESSION NUMBER: 0001213900-23-001717 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230103 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230109 DATE AS OF CHANGE: 20230109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sensus Healthcare, Inc. CENTRAL INDEX KEY: 0001494891 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 271647271 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37714 FILM NUMBER: 23518767 BUSINESS ADDRESS: STREET 1: 851 BROKEN SOUND PARKWAY NW STREET 2: SUITE 215 CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 561-922-5808 MAIL ADDRESS: STREET 1: 851 BROKEN SOUND PARKWAY NW STREET 2: SUITE 215 CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: Sensus Healthcare, LLC DATE OF NAME CHANGE: 20100622 8-K 1 ea171415-8k_sensus.htm CURRENT REPORT
0001494891 false 0001494891 2023-01-03 2023-01-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 3, 2023

 

SENSUS HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-37714   27-1647271
(State of Incorporation)   (Commission File Number)   (IRS Employer
Identification No.)

 

851 Broken Sound Pkwy., NW # 215, Boca Raton, Florida

 

33487

(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (561) 922-5808

 

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.01 per share   SRTS   Nasdaq Stock Market, LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

SENSUS HEALTHCARE, INC.

 

FORM 8-K

CURRENT REPORT

 

Item 2.02 Results of Operation and Financial Condition

 

On January 5, 2023, Sensus Healthcare, Inc. (“Sensus”) announced via press release certain information regarding its performance, including preliminary revenues for the quarter and year ended December 31, 2022. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

The information furnished under Item 2.02, including in Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

(b) and (c)

 

On January 3, 2023, Magdalena Martinez was elected Chief Operating Officer of Sensus, replacing Nicolas Soro.

 

Ms. Martinez, 33, has been with Sensus since 2013. Originally hired as a Customer Support Specialist, she provided real-time technical support and led Sensus’s team of field service engineers. She was promoted to Director of Field Operations in 2018, and most recently served as Sensus’s Vice President of Operations. Ms. Martinez’s involvement in all post-sales activities, with an emphasis in customer satisfaction, technical support, and asset management with Sentinel Cloud™ has made her an integral part of the operations team. She holds a B.A. in Business Administration from Stetson University.

 

Ms. Martinez has no family relationship that is required to be disclosed under Item 401(d) of Regulation S-K and is not a party to any related party transaction that is required to be disclosed under Item 404(a) of Regulation S-K.

 

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

99.1  Press Release, dated January 5, 2023.
104  Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SENSUS HEALTHCARE, INC.
     
Date: January 9, 2023 By: /s/ Javier Rampolla
    Javier Rampolla
    Chief Financial Officer

 

2

 

 

EXHIBIT INDEX

 

Exhibit
Number
  Description
99.1   Press Release, dated January 9, 2023.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

3

 

 

EX-99.1 2 ea171415ex99-1_sensus.htm PRESS RELEASE, DATED JANUARY 5, 2023.

Exhibit 99.1

 

 

 

 

Sensus Healthcare Announces Preliminary Fourth Quarter 2022 Revenues

Fourth quarter revenues to exceed $13 million; full year revenues to exceed $44 million, representing growth of 60%

BOCA RATON, Fla, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today reports preliminary 2022 fourth quarter and full year revenues.

Preliminary revenues for the three months ended December 31, 2022 are expected to exceed $13 million.  For the full year 2022, revenues are expected to exceed $44 million, representing growth of approximately 60% over 2021.  Fourth quarter 2022 revenues are expected to include more than $500,000 from the company’s aesthetics business.  Sensus also announces it expects that both the fourth quarter and the full year will be profitable.

“We’re delighted to report topline momentum during the fourth quarter and to share our expectations for continued growth in revenues and profitability in 2023,” said Joe Sardano, chairman and chief executive officer of Sensus Healthcare.  “Our robust marketing programs, combined with an expanded product offering and the opening of new customer channels, are expected to contribute to our growth trajectory.”

The company plans to continue adding to its domestic sales force and increase its trade show presence during 2023. Outside of the U.S., the company intends to expand geographic reach in both the EU and Latin America. It also plans to expand its product portfolio in the second half of 2023 with several submissions to the U.S. Food and Drug Administration expected to be made for new technologies.

Sensus Healthcare plans to announce 2022 fourth quarter and full year financial results and hold an investment community conference call after the close of the U.S. stock markets on February 9, 2023.  Conference call details including participation instructions will be provided at a later date.

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for both oncological and non-oncological conditions. Sensus offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100, SRT-100+ and SRT-100 Vision systems. With its portfolio of innovative medical device products, including aesthetic lasers and its needleless TransDermal Infusion System, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world. 

For more information, visit www.sensushealthcare.com.

 

Forward-Looking Statements

This press release includes statements that are or may be deemed ''forward-looking statements.'' In some cases, these statements can be identified by the use of forward-looking terminology such as "believes," "estimates," "anticipates," "expects," "plans," "intends," "may," "could," "might," "will," "should," “approximately,” "potential" or negative or other variations of those terms or comparable terminology, although not all forward-looking statements contain these words.

Forward-looking statements involve risks and uncertainties because they relate to events, developments, and circumstances relating to Sensus, our industry, and/or general economic or other conditions that may or may not occur in the future or may occur on longer or shorter timelines or to a greater or lesser degree than anticipated. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, forward-looking statements are not guarantees of future performance, and our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate may differ materially from the forward looking statements contained in this press release, as a result of the following factors, among others: the continuation and severity of the COVID-19 pandemic, including its impact on sales and marketing; our ability to achieve profitability; our ability to obtain and maintain the intellectual property needed to adequately protect our products, and our ability to avoid infringing or otherwise violating the intellectual property rights of third parties; the level and availability of government and/or third party payor reimbursement for clinical procedures using our products, and the willingness of healthcare providers to purchase our products if the level of reimbursement declines; the regulatory requirements applicable to us and our competitors; our ability to efficiently manage our manufacturing processes and costs; the risks arising from doing business in China and other foreign countries; legislation, regulation, or other governmental action that affects our products, taxes, international trade regulation, or other aspects of our business; concentration of our customers in the U.S. and China, including the concentration of sales to one particular customer in the U.S.; and other risks described from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. In addition, we note that our revenues and profits for the year ended December 31, 2022 are subject to adjustments, including adjustments that may be made in connection with the completion of our audited financial statements.

At the present time, we do not expect that the Russia-Ukraine conflict and global geopolitical uncertainty will have any particular impact on our business, but we continue to monitor developments and will address them in future disclosures, if applicable.

In addition, even if future events, developments, and circumstances are consistent with the forward-looking statements contained in this press release, they may not be predictive of results or developments in future periods. Any forward-looking statements that we make in this press release speak only as of the date of such statement, and we undertake no obligation to update such statements to reflect events or circumstances after the date of this press release, except as may be required by applicable law. You should read carefully our "Introductory Note Regarding Forward-Looking Information" and the factors described in the "Risk Factors" section of our periodic reports filed with the Securities and Exchange Commission to better understand the risks and uncertainties inherent in our business.

Contact:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
kgolodetz@lhai.com

#   #   #

 

EX-101.SCH 3 srts-20230103.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 srts-20230103_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 srts-20230103_pre.xml XBRL PRESENTATION FILE GRAPHIC 6 image_001.jpg GRAPHIC begin 644 image_001.jpg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htm IDEA: XBRL DOCUMENT v3.22.4
Cover
Jan. 03, 2023
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 03, 2023
Entity File Number 001-37714
Entity Registrant Name SENSUS HEALTHCARE, INC.
Entity Central Index Key 0001494891
Entity Tax Identification Number 27-1647271
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 851 Broken Sound Pkwy.
Entity Address, Address Line Two NW # 215
Entity Address, City or Town Boca Raton
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33487
City Area Code 561
Local Phone Number 922-5808
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol SRTS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 ea171415-8k_sensus_htm.xml IDEA: XBRL DOCUMENT 0001494891 2023-01-03 2023-01-03 iso4217:USD shares iso4217:USD shares 0001494891 false 8-K 2023-01-03 SENSUS HEALTHCARE, INC. DE 001-37714 27-1647271 851 Broken Sound Pkwy. NW # 215 Boca Raton FL 33487 561 922-5808 false false false false Common Stock, par value $0.01 per share SRTS NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://sensushealthcare.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea171415-8k_sensus.htm ea171415ex99-1_sensus.htm srts-20230103.xsd srts-20230103_lab.xml srts-20230103_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ea171415-8k_sensus.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "ea171415-8k_sensus.htm" ] }, "labelLink": { "local": [ "srts-20230103_lab.xml" ] }, "presentationLink": { "local": [ "srts-20230103_pre.xml" ] }, "schema": { "local": [ "srts-20230103.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "SRTS", "nsuri": "http://sensushealthcare.com/20230103", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "ea171415-8k_sensus.htm", "contextRef": "From2023-01-03to2023-01-03", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://sensushealthcare.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "body", "html" ], "baseRef": "ea171415-8k_sensus.htm", "contextRef": "From2023-01-03to2023-01-03", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://sensushealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0001213900-23-001717-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-001717-xbrl.zip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�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end